f# f# f# f# f# f# f# f#
12th Edition, By Mottram
f# f# f# f#
Chapter 1 - 13 Updated
f# f# f# f# f#
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
f# f# f# f# f# f# f# f#
MULTIPLE f#CHOICE
1. Who f#first f#popularized f#spirometry f#for f#the f#evaluation f#of f#pulmonary f#function?
a. August f#and f#Marie f#Krogh
b. Alvan f#Barach
c. John f#Severinghaus
d. John f#Hutchinson
ANS: f#D
Hutchinson f#popularized f#the f#concept f#of f#using f#VC f#to f#assess f#lung f#function, f#and f#the
f#names f#he f#gave f#to f#several f#other f#lung f#compartments f#are f#still f#used f#today.
DIF: 1 REF: p. f#2 OBJ: None f # MSC: f#NBRC: f#None
2. Which f#of f#the f#following f#are f#indications f#for f#performing f#spirometry?
1. Assess f#the f#risk f#of f#lung f#resection.
2. Determine f#the f#response f#to f#bronchodilator f#therapy.
3. Assess f#the f#severity f#of f#restrictive f#lung f#disease.
4. Quantify f#the f#extent f#of f#COPD.
a. 1 f # and f # 4
b. 2 f # and f # 3
c. 1 f#, f#2, f#and f # 4
d. 2 f#, f#3, f#and f # 4
ANS: f#C
Spirometry f#cannot f#assess f#severity f#of f#restriction; f#for f#that f#you f#need f#to f#measure f#lung
f#volumes f#( f#see f#Box f#1-2, f#Chapter f # 1).
DIF: 1 REF: p. f#7 OBJ: EL-2 MSC: f#NBRC: f#None
,3. The f#main f#indication f#for f#the f#measurement f#of f#lung f#volumes f#is f#to f#do f#which f#of f#the
f#following?
a. Diagnose f#or f#assess f#the f#severity f#of f#restriction.
b. Evaluate f#the f#severity f#of f#pulmonary f#hypertension.
c. Determine f#the f#level f#of f#cardiopulmonary f#fitness.
d. Assess f#the f#risk f#of f#abdominal f#surgical f#procedures.
ANS: f#A
The f#most f#common f#reason f#for f#measuring f#lung f#volumes f#is f#to f#identify f#restrictive f#lung
disease. f#DIF:
f# 1 REF: p. f#35 OBJ: EL-2 MSC: f#NBRC: f#None
4. DLCO f#measurements f#may f#be f#indicated f#to f#evaluate f#pulmonary f#involvement f#in
f#which f#of f#the f#following f#systemic f#diseases?
a. Asthma
b. Sarcoidosis
c. Exertional f#hypoxemia
, Stuvia.com f#- f#The f#Marketplace f#to f#Buy f#and f#Sell f#your f#Study
f#Material
d. Guillain-Barré f#syndrome
ANS: f#B
Sarcoidosis f#is f#the f#only f#systemic f#disease f#listed f#that f#affects f#gas
exchange. f#DIF: f#1 f#REF: f#p. f#9 f#| f#p. f#19 f#| f#p. f#21 f#| f#p. f#35 f#OBJ: f#EL-2
f#
f# MSC: f#NBRC: f#None
5. Blood f#gas f#analysis f#is f#used f#with f#patients f#with f#COPD f#to f#do f#which
f#of f#the f#following?
a. Monitor f#airway f#responsiveness.
b. Determine f#level f#of f#cardiopulmonary f#fitness.
c. Detect f#pulmonary f#hypertension.
d. Assess f#need f#for f#supplementary f#O2.
ANS: f#D
Blood f#gas f#analysis f#is f#most f#commonly f#used f#to f#determine f#the f#need f#for f#supplemental
f#oxygen f#and f#to f#manage f#patients f#who f#require f#ventilatory f#support.
DIF: 2 REF: p. f#15 OBJ: EL-1
f#MSC: f#NBRC: f#CPFT f#2A-2
6. Which f#of f#the f#following f#cause f#emphysema?
1. 1- f#Antitrypsin f#deficiency
2. Exposure f#to f#environmental f#pollutants
3. Radiation f#therapy
4. Cigarette f#smoking
a. 1 f # and f # 2
b. 3 f # and f # 4
c. 1 f#, f#2, f#and f # 4
d. 2 f#, f#3, f#and f # 4
ANS: f#C
Emphysema f#is f#caused f#primarily f#by f#cigarette f#smoking. f#Some f#emphysema f#is f#caused f#by
f#the f#absence f#of f#a f#protective f#enzyme. f#Chronic f#exposure f#to f#environmental f#pollutants
f#can f#also f#contribute f#to f#the f#development f#of f#emphysema.
DIF: 1 REF: p. f#11 OBJ: EL-3 f#| f#AL-2 MSC: f#NBRC: f#None
7. An f#adult f#patient f#complains f#of f#chest f#tightness f#and f#cough f#whenever f#he f#jogs f#in f#cold
f#weather. f#These f#symptoms f#are f#consistent f#with f#which f#of f#the f#following?
a. Cystic f#fibrosis
b. Asthma
c. Pulmonary f#hypertension
d. Idiopathic f#pulmonary f#fibrosis
|